Skip to the content
Caishen.CoCaishen.Co
Primary Data for China's Secondary Investment and Stock Markets
  • Login
  • About
  • FAQ
  • Login
  • About
  • FAQ
  • Twitter
  • LInkedIn

Company: Dashenlin Pharmaceutical Group

Zhongsheng Ruichuang's 3CL protease inhibitor clinical trial application was accepted by NMPA, and domestic new crown drugs accelerated

  • Post date May 16, 2022 — 08:44 Post Lock Login to View

Read More

The 2021 annual report of the pharmaceutical and biological industry and the summary of the first quarter of 2022 performance: the overall growth resilience is more differentiated than the sub-segments_Oriental Fortune Network

  • Post date May 13, 2022 — 20:12 Post Lock Login to View

Read More

Investment hedging guide: U.S. inflation data in April exceeded expectations, Tonghua Jinma will welcome a large-scale lifting of the ban, and Poly Development’s April contract amount decreased by 40% year-on-year

  • Post date May 12, 2022 — 08:51 Post Lock Login to View

Read More

Dashenlin: 10,112,600 shares held by Ke Jinlong, one of the controlling shareholders, are pledged, accounting for 1.28% of the company's total share capital

  • Post date May 11, 2022 — 18:56 Post Lock Login to View

Read More

Dashenlin: 10.1126 million shares held by Ke Jinlong, one of the controlling shareholders, are pledged, accounting for 1.28% of the company's total share capital.

  • Post date May 11, 2022 — 18:55 Post Lock Login to View

Read More

5.10 Yiling Brand Day Scientific and technological innovation helps Chinese pharmaceutical brands go global

  • Post date May 11, 2022 — 18:36 Post Lock Login to View

Read More

Dashenlin (603233.SH): Controlling shareholder pledged 10.1126 million shares_Stock Information_Market Gold Online

  • Post date May 11, 2022 — 18:07 Post Lock Login to View

Read More

Da Shenlin: Ke Jinlong has pledged about 59.42 million shares in total – yqqlm

  • Post date May 11, 2022 — 17:47 Post Lock Login to View

Read More

Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains

  • Post date May 10, 2022 — 10:07 Post Lock Login to View

Read More

Industry Observation Chain Pharmacy: Q1 business recovery is better than previously expected inflection point to see Q2 same store growth_Securities News_Finance Gold Online

  • Post date May 9, 2022 — 12:09 Post Lock Login to View

Read More

In order to expand the scale of 16 equity investment mergers and acquisitions during the year, the solvency of ordinary people is under pressure

  • Post date May 9, 2022 — 09:01 Post Lock Login to View

Read More

R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com

  • Post date May 9, 2022 — 04:42 Post Lock Login to View

Read More

A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline

  • Post date May 8, 2022 — 21:55 Post Lock Login to View

Read More

A-share pharmaceutical company’s expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion advertising expenses, BeiGene invests the most in R&D

  • Post date May 8, 2022 — 20:56 Post Lock Login to View

Read More

400 billion "Security Mao" evaporated 40 billion a day, how much did Feng Liu's 8.6 billion market value get hurt? Zhang Kun is also recruited, and he is also listed on the top ten tradable shareholders-Fund Channel-Hexun.com

  • Post date May 5, 2022 — 22:28 Post Lock Login to View

Read More

A-share lunch review: Shanghai index rose 1.11% in half a day, and the turnover of Ningde era exceeded 17 billion yuan

  • Post date May 5, 2022 — 11:56 Post Lock Login to View

Read More

Pharmaceutical business sector strengthens

  • Post date May 5, 2022 — 10:49 Post Lock Login to View

Read More

Medicine: The new crown nucleic acid test is normalized, the economy is stabilized, and the business recovery of the leading companies in the high-prosperity track is optimistic after the epidemic period – yqqlm

  • Post date May 5, 2022 — 08:20 Post Lock Login to View

Read More

Celebrity private equity adjustment routes in the first quarter are exposed! Gao Yi and Feng Liu cut positions in pharmaceutical stocks, and Deng Xiaofeng bucked the trend and increased positions in these stocks… The "mysterious" private equity of Maotai, a heavy warehouse, also shot Rongyi Financial Information Rongyi Information Network

  • Post date May 4, 2022 — 17:36 Post Lock Login to View

Read More

Celebrity private equity adjustment routes in the first quarter are exposed! Gao Yi and Feng Liu cut positions in pharmaceutical stocks, and Deng Xiaofeng bucked the trend and increased positions in these stocks… The "mysterious" private equity of Maotai, a heavy warehouse, also shot Rongyi Financial Information Rongyi Information Network

  • Post date May 4, 2022 — 16:30 Post Lock Login to View

Read More

Want to see more data? Registered subscribers can see all the data.

   Register Now!
  • Twitter
  • LInkedIn
  • About Us
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms and Conditions
  • Corporate Subscription

Copyright © 2025 Caishen.Co. All rights reserved.

To the top ↑ Up ↑
China Money NetworkA service of China Money Network Ltd.